The effect of waiting time on health and quality of life outcomes and costs of medication in hip replacement patients: a randomized clinical trial

Osteoarthritis and Cartilage

Volumn 17, Issue 9, 2009, Pages 1144-1150

  Tuominen, U ^a,b   Sintonen, H ^a,b   Hirvonen, J ^a   Seitsalo, S ^c   Paavolainen, P ^c   Lehto, M ^d   Hietaniemi, K ^e   Blom, M ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^d PIRKANMAA HOSPITAL DISTRICT   (Finland)

^e HOSPITAL DISTRICT OF HELSINKI AND UUSIMAA   (Finland)

Author keywords

Harris Hip Score; HRQoL, 15D; Medication; Randomization; Waiting time

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG USE; FEMALE; FOLLOW UP; HARRIS HIP SCORE; HEALTH CARE COST; HIP; HIP OSTEOARTHRITIS; HIP PAIN; HOSPITAL ADMISSION; HUMAN; JOINT FUNCTION; JOINT MOBILITY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PAIN ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; QUALITY OF LIFE; TIME FACTORS; WAITING LISTS;

EID: 68749089600     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2009.03.014     Document Type: Article

References (23)

1. Aromaa A, Koskinen S, Eds. Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey. Helsinki, 2004.
2. National Research and Development Centre for Welfare and Health. Operative Inpatient Service (2006). http://www.stakes.info/0, 1, 7.asp
3. National Health Insurance Institution. Available in: (2006). http://www.kela.fi
4. Kili S., Wright I., and Jones R.S. Change in Harris hip score in patients on the waiting list for total hip replacement. Ann R Coll Surg Engl 82 (2001) 2
5. Croft P., Lewis M., Wynn Jones C., Coggon D., and Cooper C. Health status in patients awaiting hip replacement for osteoarthritis. Reumatology 41 (2002) 9
6. Hajat S., Fitzpatrik R., Morris R., et al. Does waiting for total hip replacement surgery matter? Prospective cohort study. J Health Serv Res Policy 7 (2002)
7. Fielden J.M., Cumming J.M., Horne J.G., Devane P.A., Slack A., and Gallagher L.M. Waiting for hip arthroplasty economic costs and health outcomes. J Arthroplasty 20 (2005) 8
8. March L., Cross M., Tribe K., Lapsley H., Courtenay B., and Brooks P. Costs of joint replacement surgery for osteoarthritis: the patients' perspective. J Rheumatol 29 (2002) 1006
9. Sintonen H. The 15D measure of health-related quality of life. Properties and applications. Ann Med 33 (2001) 328-336
10. Sintonen H. Outcome measurement in acid-related diseases. PharmacoEconomics 5 Suppl 3 (1994) 17-24
11. Sintonen H. The 15D Measure of Health-related Quality of Life. II Feasibility and Validity of its Valuation System (1995), National Centre for Health Program Evaluation, Melbourne. Working paper 42, Available from: http://www.buseco.monash.edu.au/centres/che/publication.php#4
12. Rissanen P., Aro S., Sintonen H., Asikainen K., Slätis P., and Paavolainen P. Costs and cost-effectiveness in hip and knee replacements. A prospective study. Int J Technol Assess Health Care 13 (1997) 575-588
13. Brazier J., and Derveril M.I. The use of health-related quality of life measures in economic evaluation. Health Services Research Methods. Guide to Best Practice (1998), BMJ Books, London
14. Stavem K. Reliability, validity and responsiveness of two ultiattribute utility measures in patients with chronic obstructive pulmonary disease. Qual Life Res 8 1-2 (1999) 45-54
15. Harris W. Traumatic arthritis of hip after dislocation and asetabular fractures: treatment by mold arthroplasty. J Bone Joint Surg Am 51 (1969) 4
16. Hawthorne G., Richardson J., and Day N.A. A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Ann Med 33 (2001) 358-370
17. Pharmaceutical Information Centre in Finland: Pharmaca Fennica CD-rom 1, 2004.
18. Hollis S., and Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319 (1999) 670-674
19. Hirvonen J., Blom M., Tuominen U., Seitsalo S., Lehto M., Paavolainen P., et al. Is longer waiting time associated with health and social services utilization before treatment? A randomized study. J Health Serv Res Policy 12 4 (2007 Oct) 209-214
20. Kelly K.D., Voaklander D.C., Johnston D.W.C., Newman S.C., and Suarez-Almazor M.E. Change in pain and function while waiting for major joint arthroplasty. J Arthroplasty 16 3 (2001) 351-359
21. Hirvonen J., Blom M., Tuominen U., and Sintonen H. The use of Patients-Reported Outcomes (PROs) in patients who underwent major joint replacement and those who left the queue. Patient Reported Outcomes. Newsletter 36 (2006) 31-32
22. Räsänen P., Paavolainen P., Sintonen H., et al. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthopaedica 78 1 (2007) 108-115
23. Wilke R.J., Burke L.B., and Erickson P. Measuring the treatment impact: a review of patients-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials 25 (2004) 535-552